EUVIMEDEUVIMED entdecken
VergleichsstudieKohortenstudie

Comparative Effectiveness of Recombinant Zoster and Live Attenuated Zoster Vaccines in Chronic Inflammatory Skin Diseases: A Retrospective Cohort Study

Cheryl Lee iD, Sheng-Hsiang Ma iD, Wei-Fan Ou, Chen-Yi Wu, Chih-Chiang Chen, Tai-Li Chen iD

Journal of Medical Virology · 2026

DOI: 10.1002/jmv.70893 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Journal of Medical Virology, 2026. Verfasst von Cheryl Lee und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rice University, Houston, Texas, USA. Hauptthemen laut MEDLINE: Herpes Zoster Vaccine, Herpes Zoster, Vaccine Efficacy, Skin Diseases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Yin Shu-Tien Foundation, Taipei Veterans General Hospital-National Yang Ming Chiao Tung University Excellent Physician Scientists Cultivation Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Patients with chronic inflammatory skin diseases (CISDs) are at an elevated risk for herpes zoster (HZ) and its complications. Therefore, effective prevention strategies are crucial for this high‐risk population. This study aimed to compare the vaccine effectiveness of recombinant zoster vaccine (RZV) versus live attenuated vaccine (LAV) in patients with CISDs. A retrospective cohort study was performed using data from the U.S. Collaborative Network of TriNetX. Adults aged ≥ 18 years with CISDs between 2014 and 2020 were included. The primary outcome was incident HZ; secondary outcomes included ophthalmic zoster (OZ), postherpetic neuralgia (PHN), and complicated HZ. Propensity score matching was performed for head‐to‐head comparisons, and Cox proportional hazards models were used to estimate hazard ratios (HRs). Compared with LAV, patients receiving RZV had a significantly lower risk of HZ (two‐dose RZV: HR 0.61; 95% CI, 0.54–0.69; one‐dose RZV: HR 0.65; 95% CI, 0.58–0.75). RZV was also associated with reduced risks of OZ, PHN, and complicated HZ. Subgroup analyses showed consistent risk reduction across patients with psoriasis, atopic dermatitis, hidradenitis suppurativa, vitiligo, and pemphigoid, as well as among adults aged ≥ 65 years. RZV is more effective than LAV in preventing HZ and its complications such as ophthalmic zoster and postherpetic neuralgia among patients with CISDs. These findings provide real‐world evidence that prioritize RZV use in this population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Herpes Zoster VaccineHerpes ZosterVaccine EfficacySkin DiseasesHumansRetrospective StudiesFemaleMaleVaccines, AttenuatedAgedMiddle AgedVaccines, SyntheticNeuralgia, PostherpeticChronic DiseaseAdultAged, 80 and over

Stichwörter der Autor:innen

ShingrixZostavaxchronic inflammatory skin diseaseherpes zosterlive attenuated vaccinepostherpetic neuralgiarecombinant zoster vaccineshingles

Substanzen

Herpes Zoster VaccineVaccines, AttenuatedVaccines, Synthetic

Autor:innen und Institutionen

  • Rice University, Houston, Texas, USA.
  • Department of Dermatology, Taipei Veterans General Hospital, Taipei, Taiwan.
  • Faculty of Medicine, School of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Institute of Public Health and Department of Public Health, National Yang Ming Chiao Tung University, Taipei, Taiwan.
  • Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  • Department of Dermatology, National Yang Ming Chiao Tung University, Taipei, Taiwan.

ORCID-Profile: Cheryl Lee, Sheng-Hsiang Ma, Tai-Li Chen

Förderung

  • Yin Shu-Tien Foundation, Taipei Veterans General Hospital-National Yang Ming Chiao Tung University Excellent Physician Scientists Cultivation Program

Zitieren

APA

Lee, C., Ma, S. H., Ou, W. F., Wu, C. Y., Chen, C. C., & Chen, T. L. (2026). Comparative Effectiveness of Recombinant Zoster and Live Attenuated Zoster Vaccines in Chronic Inflammatory Skin Diseases: A Retrospective Cohort Study. Journal of Medical Virology. https://doi.org/10.1002/jmv.70893

Vancouver

Lee C, Ma SH, Ou WF, Wu CY, Chen CC, Chen TL. Comparative Effectiveness of Recombinant Zoster and Live Attenuated Zoster Vaccines in Chronic Inflammatory Skin Diseases: A Retrospective Cohort Study. Journal of Medical Virology. 2026. doi:10.1002/jmv.70893

BibTeX
@article{Lee2026,
  author = {Lee, Cheryl and Ma, Sheng-Hsiang and Ou, Wei-Fan and Wu, Chen-Yi and Chen, Chih-Chiang and Chen, Tai-Li},
  title = {Comparative Effectiveness of Recombinant Zoster and Live Attenuated Zoster Vaccines in Chronic Inflammatory Skin Diseases: A Retrospective Cohort Study},
  journal = {Journal of Medical Virology},
  year = {2026},
  doi = {10.1002/jmv.70893}
}
Kostenlos starten →